MYELOID NEOPLASIA Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia

1Department of Clinical Chemistry and Transfusion Medicine, University of Gothenburg, Gothenburg, Sweden; 2Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; 3Center of Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway; 4Laboratory of Immunohematology, Department of Hematology, Aarhus University Hospital, Aarhus, Denmark; 5Department of Pediatrics, Sahlgrenska University Hospital, Gothenburg, Sweden; 6Department of Medical Biosciences, Umeå University, Umeå, Sweden; 7Department of Pediatrics, University Central Hospital of Helsinki, Helsinki, Finland; 8Department of Pediatrics, University Hospital, Reykjavik, Iceland; 9Department of Pediatrics, Oslo University Hospital, Oslo, Norway; 10Department of Women’s and Children’s Health, University Children’s Hospital, Uppsala, Sweden; 11Department of Pediatrics, Aarhus University Hospital Skejby, Aarhus, Denmark; and 12Department of Clinical Genetics, Lund University, Lund, Sweden